The genetic diversity and genotypic drug susceptibility of HIV-1 strains circulating in the Republic of Georgia, formerly part of the Soviet Union, were investigated for first time. Forty-eight HIV-positive drug-naive Georgian individuals contributed PBMC DNA between 1998 and 2003. On the basis of phylogenetic analyses of partial pol sequences, the predominant HIV-1 genetic forms were subtype A (70%), followed by subtype B (26%); both genetic forms were carried by injecting drug users and heterosexuals. There was also one subtype C (2%) and one CRF18_cpx (2%). The Georgian subtype A strains clustered with subtype A from Russia, designated A FSU . Twelve of the subtype A strains (25%) contained the secondary protease inhibitor mutation V77I and 9 also had two other silent mutations. This "V77I haplotype" marks one particular genetic lineage of the epidemic in the former Soviet Union. Two strains (4%) carried antiretroviral (ARV) drug resistance mutations. Nearly full-length genome sequences of five Georgian strains were also completed. Two, 98GEMZ011 (subtype A) and 98GEMZ003 (subtype B), closely resembled the parental strains that recombined to create CRF03_AB. The use of these parental strains in the analysis revealed an additional segment of subtype A in CRF03_AB. Thus, the HIV-1 epidemic in Georgia was composed of a mixture of subtype A FSU and subtype B.
INTRODUCTION I
N THE REPUBLICS OF THE FORMER SOVIET UNION (FSU), an epidemic of HIV-1 infection associated with injecting drug use (IDU) has been noted since 1996. 1, 2 The prevalence of HIV in this epidemic has increased steadily over time and the UNAIDS Program estimated that the epidemic is growing faster in the FSU than in any other region of world. 3 Between 1996 and 1997, three highly homogeneous variants of HIV-1 were found to circulate among IDUs in the FSU. 4, 5 One of these was HIV-1 genetic subtype A, another was subtype B, and the third was a recombinant between the first two variants, later designated a circulating recombinant form, CRFO3_AB. 5 The epidemic that began in drug-using networks in the mid1990s has spread beyond that core group in Russia, Ukraine, Belarus, and Moldova. 3 Of the three strains that were originally introduced, the one responsible for the spreading epidemic was subtype A, a subtype common only in Africa. 2 Thus the FSU epidemic was clearly distinct from the HIV epidemic in Europe, where subtype B was the most common subtype. 6, 7 In addition, the strain of subtype A in the FSU was monophyletic, suggesting that they all descended from one ancestor. HIV strains that clustered phylogenetically with these A strains were designated "A FSU ." 8 The first case of HIV in Georgia was diagnosed in 1989. 9 From then until December 2002, a total of 375 cases of HIV infection has been reported. 10 The World Health Organization (WHO, Geneva, Switzerland), however, estimated that the true number of prevalent infections was much larger, with approximately 1700 infected persons (including 180 women of repro-ductive age). 11 Most of the reported cases were from Tbilisi, the capital of Georgia, and from cities along the Black Sea coast. The majority of infected people in Georgia consisted of male IDUs and their sexual partners. IDUs account for 69.9% of the cases, 23.7% are thought to have been acquired through heterosexual contact, and 4% through homosexual contact. 11 Thus far, all reported infections have been caused by HIV-1; no cases of HIV-2 infection have been reported. 10 Antiretroviral therapy (ART) is being introduced in Georgia and the experience of other countries has shown that the prevalence of drug resistance mutations will rise in parallel with its use. 12 Current antiretroviral (ARV) drugs target two enzymes essential for viral replication: reverse transcriptase (RT) and protease. RT inhibitors, both nucleoside RT inhibitors (NRTIs) and nonnucleoside inhibitors (NNRTIs), suppress a relatively early step in virus replication. In contrast, protease inhibitors (PIs) act later in the virus life cycle.
ARV drug effectiveness will doubtless be complicated by the development of drug-resistant HIV-1 variants. 13 Drug resistance mutations in the protease gene are subdivided into two groups: primary mutations that result directly in drug resistance, but the replicative capacity of the virus is often decreased, and secondary mutations that are not associated with drug resistance directly but confer higher levels of resistance and improve viral fitness in strains carrying primary mutations. 14 The frequency of primary mutations in PI-naive populations is usually low; the frequency of the secondary mutations in such populations may be considerably higher. 13 An example of this is the PI V77I mutation, which is a secondary mutation frequently found in combination with the primary mutation, PI D30N, determining resistance to nelfinavir in subtype B isolates. 15 The resistance mutation, PI V77I, was found in more than half of the subtype A nucleotide sequences derived from HIV-1-infected individuals from the Russian Federation. 16 It was often accompanied by two synonymous mutations: ACAϾACG in the triplet coding for Thr-31 and GGAϾGGG in the triplet for Gly-78, which formed a "signature" for one lineage of A FSU spreading in the FSU. 16 On the basis of the classification developed by UNAIDS, Georgia has a low-level HIV epidemic because the prevalence of HIV-1 is less than 1% even in high-risk groups. 11 However, the high prevalence of IDUs, flourishing commercial sex, a dramatic rise in STDs, severe economic conditions, rising HIV incidence in neighboring countries, and significant population migration have made Georgia particularly vulnerable to the spread of HIV-1. The introduction of ARV drugs into this fluid environment reinforces the need to monitor the epidemic for the emergence of new variants.
MATERIALS AND METHODS

Study subjects
At the Georgian Infectious Diseases, AIDS, and Clinical Immunology Research Center (Tbilis, Georgia), heparinized whole blood was collected from 48 drug-naive HIV-1-infected individuals. The samples were drawn in October to December 1998 and in May to August 2003 and represented different transmission modes.
DNA extraction
Peripheral blood mononuclear cells (PBMCs) were purified by Ficoll-Hypaque gradient centrifugation. Genomic DNA was extracted from PBMCs using the QIAgen blood and tissue technique (QIAgen, Valencia, CA).
PCR amplification A 1.1-kb fragment of the HIV-1 pol gene was amplified from PBMC DNA by nested PCR, using primers Pro5F (5Ј-AGAAATTGCAGGGCCCCTAGGAA-3Ј) and RT347 (5Ј-GAATCTCTGTTTTVTGCCAGTTC-3Ј) for the first round and Pro3F (5Ј-AGATCAGAGCCAACAGCCCCACCA-3Ј) and ProRT (5Ј-TTTCCCCACTAACTTCTGTATGTCATTG-ACA-3Ј) for the second round, as described previously. 8 The amplicon contained the coding sequences for the protease protein and part of the reverse transcriptase protein (RT), corresponding to nucleotide 2253-3266 on HXB-2 (GenBank accession number K03455), and is referred to as the "Pro/RT" amplicon.
PCR amplification of the nearly full genome of HIV-1 was also performed for selected samples, using a nested strategy described elsewhere. 17, 18 This amplicon is approximately 9 kb in length and includes all of the genome of HIV except for U5 of the long terminal repeat (LTR) and the gag leader region.
DNA sequencing
Using a Microcon YM-50 column (Millipore, Bedford, MA), amplified products from the second-round PCR were purified. The DNA fragments were then further purified with a dye removal and sequencing reaction clean-up process, using Sephadex G-50 Superfine (Amersham Pharmacia Biotech, Uppsala, Sweden) in MultiScreen 96-well filtration plates (Millipore). The DNA fragments were detected on an ABI PRISM 3100 DNA capillary sequencer (Applied Biosystems, Foster City, CA). DNA sequences from both strands were edited with the Sequencing analysis 3.3 program (Applied Biosystems) and then assembled with Sequencher 4.1 software (Genecodes, Ann Arbor, MI). All sequence ambiguities were resolved.
Phylogenetic analysis
Multiple alignments of the partial pol and nearly fulllength sequences were created with selected reference isolates obtained from the Los Alamos National Laboratory HIV Sequence Database (http://www.hiv.lanl.gov/content/hivdb/SUBTYPE_ REF/align.html). In addition to these reference sequences, the following were also added: 98UAO116 from Ukraine, 03RU20 and B.RU.04 from Russia, 97BL006 from Byelorussia, and strains from Ukraine and Uzbekistan with GenBank accession numbers DQ055174-DQ055336 and AY845716-AY845857, respectively. An example of CRF18_cpx from Cameroon, CAM53379, and CRF03_AB from Kaliningrad, Russia, Kal153, were also included in the alignment.
Phylogenetic trees were generated, and the consistency of branching order was evaluated with SEQBOOT, DNADIST,
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NEIGHBOR, and CONSENSE modules of the Phylip package (V3.52c). 19 Parsimony bootstrap analysis was done to assess the stability of the branching order and a bootstrap value equal to or greater than 70% was considered definitive. Recombinant analysis, bootscanning, and distance scanning was performed with Simplot v3.4 with a window size of 300 nucleotides. 20 Recombination breakpoints were identified relative to HXB-2. To investigate the ARV drug resistance patterns of the strains, the ProRT sequences were analyzed for resistance mutations, using the Stanford HIV Drug Resistance Database. 21 ZARANDIA ET AL. 472 Susceptible  WT  GGG  ACG  99GEMZ011  M  UA  IDU  A  Susceptible  WT  GGG  WT  03GEMZ007  F  GE  HET  A  Susceptible  WT  GGG  WT  03GEMZ031  M  GE  IDU  A  Susceptible  WT  GGG  WT  03GEMZ038  M  GE  IDU  A  Susceptible  WT  GGG  WT  03GEMZ036  F  GE  IDU  A  Susceptible  WT  WT  ACG  98GEMZ005  M  UA  IDU  A  Susceptible  WT  WT  WT  98GEMZ007  F  GE  HET  A  Susceptible  WT  WT  WT  99GEMZ012  F  GE  HET  A  Susceptible  WT  WT  WT  99GEMZ013  M  GE  IDU  A  Susceptible  WT  WT  WT  98GEMZ008  M  GE  IDU  A  Susceptible  WT  WT  WT  03GEMZ012  F  GE  HET  A  Susceptible  WT  WT  WT  03GEMZ017  F  GE  HET  A  Susceptible  WT  WT  WT  03GEMZ019  M  GE  IDU  A  Susceptible  WT  WT  WT  03GEMZ011  M  GE  HET  A  Susceptible  WT  WT  WT  03GEMZ021  F  GE  HET  A  Susceptible  WT  WT  WT  03GEMZ027  M  GE  IDU  A  Susceptible  WT  WT  WT  03GEMZ032  M  GE  IDU  A  Susceptible  WT  WT  WT  03GEMZ037  M  GE  IDU  A  Susceptible  WT  WT  WT Abbreviations: BU, Bulgaria; F, female; FSW, female sex worker; GE, Georgia; HET, heterosexual contact; IDU, injection drug user; M, male; MD, Moldova; MSM, man having sex with man; NRTI, nonreverse transcriptase inhibitor; PI, protease inhibitor; TRANSF, transfusion; UA, Ukraine; WT, wild type. 
Nucleotide sequences
Sequences of ProRT and nearly full-length genomes have been deposited in GenBank with the following accession numbers: DQ205252-DQ205294 and DQ207940-DQ207944, respectively.
RESULTS
In the study population of 48, 33 (69%) were male, 15 (31%) were female, and the majority of study subjects were between 19 and 43 years of age (mean age, 26 years). Most of the subjects (73%) were from Tbilisi, the capital of Georgia, but the remaining 13 (27%) were from four regions in the western part of Georgia: Samegrelo, Adjara, Imerety, and Svaneti. All subjects were citizens of Georgia; 12 samples were collected between 1998 and 1999, while the remaining samples were collected in 2003. Thirty-one (64%) identified themselves as IDUs, 13 (27%) were infected by heterosexual contact (HET), 1 man had sex with men (MSM), and 2 were infected by blood transfusion (Table 1) . One individual was a female sex worker (FSW) who reported contact with both Georgians and foreigners. Most of the subjects were infected in Georgia, although three had shared needles while in Ukraine or Moldova and one reported acquiring the infection in Bulgaria (Table 1) .
The partial pol sequences acquired from 48 drug-naive Georgian individuals were phylogenetically analyzed with sequences from other regions of the former Soviet Union as well as reference sequences for each subtype (Fig. 1A) . The predominant genetic form circulating in Georgia was subtype A (70%), and specifically the genetic form of subtype A that is common in other parts of the region, including Ukraine, Russia, and Uzbekistan (A FSU ). Individuals infected through injecting drugs as well as those infected heterosexually were infected with subtype A, although it was slightly more common in IDUs than in others ( Table 1 ). The next most common genetic form was subtype B (26%) (Fig. 1B) . One subtype C strain was found in a FSW who reported exposures to clients from outside of Georgia (Table 1) . One strain, reportedly transmitted by a transfusion, was CRF18_cpx and clustered with CAM53379, a strain from Cameroon. Three of the 48 strains in the total population consisted of hypermutated sequences.
All of the subtype A strains from Georgia clustered with the subtype A strain from Kenya (Q23) (bootstrap, 83%) and, in a deeper node, with subtype A from other parts of the former Soviet Union (A FSU ) (Fig. 1A) . This genetic cluster included strains from Ukraine, Russia, Uzbekistan, and Belarus (boot- strap, 98%). There was also one significant large cluster of strains within the A FSU node (bootstrap, 84%). It was composed of 1 Russian strain, 4 Uzbek strains, and 13 Georgian strains.
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To investigate the level of primary resistance in strains circulating in Georgia, the DNA encoding protease and part of reverse transcriptase was analyzed for drug resistance mutations found in subtype B-infected patients. Among the 48 strains, 2 carried the primary resistance mutation RT M184V/I: 1 of them was subtype A and 1 was subtype B ( Table 1 ). The remaining strains were assumed to be susceptible, inasmuch as they lacked any of the primary resistance mutations documented for subtype B.
There were no primary resistance mutations to PIs in this data set. The substitution I93L, a secondary PI mutation, was found in all of the Georgian samples, regardless of subtype. Twelve sequences (25%) contained the secondary protease mutation V77I. Eleven of these 12 were subtype A and clustered with Uzbekistan and Russian strains bearing the same mutation (Fig. 1A) . V77I was genetically linked to two synonymous substitutions in protease, silent mutations in the codons for Thr-31 and Gly-78, suggesting that all V77I-bearing viruses evolved from a single source (Table 1) . The combination of all three mutations will be referred to as the V77I "haplotype." Only one subtype B strain carried the V77I mutation and it did not have the synonymous substitutions characterizing the haplotype ( Table 1) .
Analysis of the sequence of RT for secondary mutations revealed that the secondary mutation A158S was universal in all strains from the Republic of Georgia. In the Georgian subtype A strains there were also six strains with the mutation A62V (19.4%), which is rare in drug-naive, subtype B-infected strains (Ͻ0.01%). Neither of these mutations confers NRTI resistance by itself, but they might contribute to that phenotype in the presence of other primary mutations.
Five viral strains were chosen for full genome characterization: three subtype B, one subtype A, and one subtype C. Full genome characterization of the five confirmed their phylogenetic classification and recombinant analysis demonstrated that they were nonrecombinant (data not shown). The subtype A strain 99GEMZ011 clustered significantly with the other fulllength sequence from the former Soviet Union, 97BL006 (bootstrap, 100%) (Fig. 2) . Three subtype B strains were fully sequenced, one of which (98GEMZ003) was from a male IDU.
In 1996, an epidemic of HIV infection began among IDUs in Kaliningrad, Russia. A circulating recombinant form resulting from the recombination of subtypes A and B, CRF03_AB, was responsible for the epidemic. The prototype strain for CRF03_AB is Kal153, from Kaliningrad. The parental strains of both elements of the recombinant, one subtype A and one subtype B, were probably in circulation in the IDU networks at the time and two of the Georgian strains appear to be genetically close to those parental strains. Bootscan analysis, using 99GEMZ011 as the subtype A parent and 98GEMZ003 as the subtype B parent for CRF03_AB, demonstrated almost perfect similarity with the respective regions of Kal153 (Fig. 3) . The close genetic relationship resulted in a more accurate map of the structure of CRF03_AB, revealing an additional segment of subtype A at positions 4806-5051 (in HXB2).
DISCUSSION
The HIV-1 epidemic in Georgia has opened another window on the IDU-based epidemic in the former Soviet Union. It is known that CRFO3_AB, the circulating recombinant form found in Kaliningrad, was formed from two parental forms, one each of subtype A and subtype B. 5 A virus similar to the parental A virus has been sequenced in full (98BL006) and many have reported strains that are genetically similar in IDU communities from Latvia to Uzbekistan; the strain is referred to as "A FSU ." 8 This report extends what is known about the geographical range of this virus by its detection in Tbilisi, Georgia.
One Georgian stain (04GEMZ039), reportedly transmitted by a blood transfusion, was a complex recombinant that clustered with CAM53379. CAM53379 has been designated CRF18_cpx and has been found in Central West Africa and in Cuba. 22 Unfortunately, the Georgian sequence was only a partial pol sequence and thus it is not known whether the entire virus is CRF18_cpx.
In 2004, there was a report describing the emergence of the secondary drug resistance mutation in protease, V77I, which was associated with A FSU in many different regions of the former Soviet Union. 16 The V77I mutation was also accompanied by two synonymous changes in the nucle otides encoding Thr-31 and Gly-78 that was characteristic of this group of virus isolates from Russia. Since the subjects were drug naive, the resistance mutation was likely a lineage marker rather than the result of natural selection for drug resistance. The combination of these three mutations has been designated the V77I haplotype. The V77I mutation was observed in 12 of 34 (35%) subtype A sequences and only one subtype B sequence (8%) ( Table 1 ). All of the V77I strains were contained in a single significant genetic cluster, indicating a single phylogenetic lineage, although there were also a few wild-type strains in the same cluster (Fig. 1A) . Nine of the 12 Georgian subtype A strains with the V77I substitution had the entire haplotype, while the subtype B strain did not.
The HIV-1 epidemic in Georgia was a mixture of subtype B strains, most likely coming from Western Europe, and subtype A strains, most likely from the FSU. Both subtypes were circulating in both IDUs and heterosexuals. While primary ARV drug resistance mutations were rare in this drug-naive population, secondary mutations were not uncommon. There is, therefore, considerable potential for the emergence of intersubtype recombination and drug resistance in the future.
